By siRNA-mediated knockdown of AR in prostate cancer cell lines, miR-32 was found to be upregulated and to enhance NSE activity, thereby promoting neuroendocrine differentiation of the prostate cancer cells [90]. The gene discussed is AR; the disease is prostate carcinoma.